Level/ Typ |
Code |
Anzeigename |
Codesystem |
0‑S |
100
|
Blutgruppenserologie
|
1.2.40.0.34.5.11 |
1‑S |
01850
|
Blutgruppenserologie
|
1.2.40.0.34.5.11 |
2‑L |
883-9
|
Blutgruppe AB0
|
2.16.840.1.113883.6.1 |
2‑L |
V00432-7
|
Blutgruppe AB0 Kontr
|
1.2.40.0.34.5.11 |
2‑L |
57743-7
|
Blutgruppe AB0 Best.
|
2.16.840.1.113883.6.1 |
2‑L |
51892-8
|
Blutgruppe AB0 /BCO
|
2.16.840.1.113883.6.1 |
2‑L |
14580-5
|
Blutgruppe AB0 Neug.
|
2.16.840.1.113883.6.1 |
2‑L |
882-1
|
Blutgruppe AB0 + Rh
|
2.16.840.1.113883.6.1 |
2‑L |
V00434-3
|
Blutgr. AB0+Rh Kontr
|
1.2.40.0.34.5.11 |
2‑L |
V00433-5
|
Blutgruppe AB0+Rh Bt
|
1.2.40.0.34.5.11 |
2‑L |
34474-7
|
Blutgr. AB0+Rh /BCO
|
2.16.840.1.113883.6.1 |
2‑L |
19057-9
|
Blutgr. AB0+Rh Neug.
|
2.16.840.1.113883.6.1 |
2‑L |
10331-7
|
Rhesusfaktor
|
2.16.840.1.113883.6.1 |
2‑L |
V00435-0
|
Rhesusfaktor Kontr.
|
1.2.40.0.34.5.11 |
2‑L |
34961-3
|
Rhesusfaktor Best.
|
2.16.840.1.113883.6.1 |
2‑L |
14906-2
|
Rhesusfaktor /BCO
|
2.16.840.1.113883.6.1 |
2‑L |
14908-8
|
Rhesusfaktor Neugeb.
|
2.16.840.1.113883.6.1 |
2‑L |
890-4
|
Blutgr. AK-Screen
|
2.16.840.1.113883.6.1 |
2‑L |
888-8
|
Blutgruppen AK-Diff.
|
2.16.840.1.113883.6.1 |
2‑L |
906-8
|
Blutgruppen AG-Best.
|
2.16.840.1.113883.6.1 |
2‑L |
907-6
|
EK. Blutgr. AG-Best.
|
2.16.840.1.113883.6.1 |
2‑L |
1250-0
|
Kreuzprobe (major)
|
2.16.840.1.113883.6.1 |
2‑L |
1007-4
|
DCT polyspez.
|
2.16.840.1.113883.6.1 |
2‑L |
55776-9
|
DCT IgG-spez.
|
2.16.840.1.113883.6.1 |
2‑L |
55775-1
|
DCT IgA-spez.
|
2.16.840.1.113883.6.1 |
2‑L |
55777-7
|
DCT IgM-spez.
|
2.16.840.1.113883.6.1 |
2‑L |
56471-6
|
DCT C3c-spez.
|
2.16.840.1.113883.6.1 |
2‑L |
55774-4
|
DCT C3d-spez.
|
2.16.840.1.113883.6.1 |
2‑L |
1008-2
|
ICT polyspez.
|
2.16.840.1.113883.6.1 |
2‑L |
34477-0
|
BG. AK-Diff.Elution
|
2.16.840.1.113883.6.1 |
2‑L |
61406-5
|
Blutgr.-AK Titer
|
2.16.840.1.113883.6.1 |
2‑L |
13310-8
|
Blutgr. K-Antigen
|
2.16.840.1.113883.6.1 |
2‑L |
972-0
|
Blutgr. Dweak-AG
|
2.16.840.1.113883.6.1 |
2‑L |
1303-7
|
BG-Serumgegenprobe
|
2.16.840.1.113883.6.1 |
2‑L |
817-7
|
Blutgr. A AK
|
2.16.840.1.113883.6.1 |
2‑L |
913-4
|
Blutgr. B AK
|
2.16.840.1.113883.6.1 |
2‑L |
975-3
|
Anti-D
|
2.16.840.1.113883.6.1 |
2‑L |
14658-9
|
Kälteagglutinine Ttr
|
2.16.840.1.113883.6.1 |
2‑L |
5097-1
|
Kälteagglutinine ql
|
2.16.840.1.113883.6.1 |
2‑L |
19066-0
|
Kommentar Blutgruppenserologie
|
2.16.840.1.113883.6.1 |
1‑S |
01860
|
HLA-Diagnostik
|
1.2.40.0.34.5.11 |
2‑L |
42675-9
|
HLA-Antigene
|
2.16.840.1.113883.6.1 |
2‑L |
4821-5
|
HLA-B27 ql.
|
2.16.840.1.113883.6.1 |
2‑L |
26028-1
|
HLA-B27 (Flowzytom.)
|
2.16.840.1.113883.6.1 |
2‑L |
45023-9
|
HLA Typ Zöliakie
|
2.16.840.1.113883.6.1 |
1‑S |
01870
|
HPA-Diagnostik
|
1.2.40.0.34.5.11 |
2‑L |
50604-8
|
HPA-Befund
|
2.16.840.1.113883.6.1 |
0‑S |
200
|
Blutgasanalytik
|
1.2.40.0.34.5.11 |
1‑S |
02060
|
Blutgasanalyse arteriell
|
1.2.40.0.34.5.11 |
2‑L |
24336-0
|
BGA Anf. art.
|
2.16.840.1.113883.6.1 |
2‑L |
2744-1
|
pH art.
|
2.16.840.1.113883.6.1 |
2‑L |
2019-8
|
pCO2 art.
|
2.16.840.1.113883.6.1 |
2‑L |
2703-7
|
pO2 art.
|
2.16.840.1.113883.6.1 |
2‑L |
19214-6
|
pO2-50 art.
|
2.16.840.1.113883.6.1 |
2‑L |
2714-4
|
Oxygen.Hämoglob. art.
|
2.16.840.1.113883.6.1 |
2‑L |
72326-2
|
Shunt-Vol. fkt. art.
|
2.16.840.1.113883.6.1 |
2‑L |
2708-6
|
O2-Sättigung art.
|
2.16.840.1.113883.6.1 |
2‑L |
59413-5
|
O2-Sättigung art. pT
|
2.16.840.1.113883.6.1 |
2‑L |
1925-7
|
Base excess art.
|
2.16.840.1.113883.6.1 |
2‑L |
19235-1
|
SBEC art.
|
2.16.840.1.113883.6.1 |
2‑L |
1960-4
|
Bikarbonat art.
|
2.16.840.1.113883.6.1 |
2‑L |
19230-2
|
Bikarbonat Std. BA
|
2.16.840.1.113883.6.1 |
2‑L |
2518-9
|
Laktat art.
|
2.16.840.1.113883.6.1 |
2‑L |
32717-1
|
Natrium art.
|
2.16.840.1.113883.6.1 |
2‑L |
32713-0
|
Kalium art.
|
2.16.840.1.113883.6.1 |
2‑L |
34581-9
|
Calcium ion. art.
|
2.16.840.1.113883.6.1 |
2‑L |
41650-3
|
Chlorid art.
|
2.16.840.1.113883.6.1 |
2‑L |
73581-1
|
Anionenlücke 4P art.
|
2.16.840.1.113883.6.1 |
2‑L |
59827-6
|
Bilirubin art.
|
2.16.840.1.113883.6.1 |
2‑L |
41651-1
|
Glucose art.
|
2.16.840.1.113883.6.1 |
2‑L |
21232-4
|
Kreatinin art.
|
2.16.840.1.113883.6.1 |
2‑L |
32354-3
|
Hct art.
|
2.16.840.1.113883.6.1 |
1‑S |
02070
|
Hb-Derivate arteriell
|
1.2.40.0.34.5.11 |
2‑L |
30313-1
|
Hämoglobin art.
|
2.16.840.1.113883.6.1 |
2‑L |
19225-2
|
Deoxy.Hämoglob. art.
|
2.16.840.1.113883.6.1 |
2‑L |
2030-5
|
Carboxyhämoglob. art
|
2.16.840.1.113883.6.1 |
2‑L |
2615-3
|
Methämoglobin art.
|
2.16.840.1.113883.6.1 |
2‑L |
V00230
|
Sulfhämoglobin art.
|
1.2.40.0.34.5.11 |
1‑S |
02080
|
Blutgasanalyse venös
|
1.2.40.0.34.5.11 |
2‑L |
24339-4
|
BGA Anf. ven.
|
2.16.840.1.113883.6.1 |
2‑L |
2746-6
|
pH ven.
|
2.16.840.1.113883.6.1 |
2‑L |
2021-4
|
pCO2 ven.
|
2.16.840.1.113883.6.1 |
2‑L |
2705-2
|
pO2 ven.
|
2.16.840.1.113883.6.1 |
2‑L |
19216-1
|
pO2-50 venös
|
2.16.840.1.113883.6.1 |
2‑L |
2716-9
|
Oxygen.Hämoglob. ven.
|
2.16.840.1.113883.6.1 |
2‑L |
2711-0
|
O2-Sättigung ven.
|
2.16.840.1.113883.6.1 |
2‑L |
1927-3
|
Base excess ven.
|
2.16.840.1.113883.6.1 |
2‑L |
14627-4
|
Bikarbonat ven.
|
2.16.840.1.113883.6.1 |
2‑L |
19232-8
|
Bikarbonat Std. BV
|
2.16.840.1.113883.6.1 |
2‑L |
2519-7
|
Laktat ven.
|
2.16.840.1.113883.6.1 |
2‑L |
39791-9
|
Natrium ven.
|
2.16.840.1.113883.6.1 |
2‑L |
39789-3
|
Kalium ven.
|
2.16.840.1.113883.6.1 |
2‑L |
41649-5
|
Chlorid ven.
|
2.16.840.1.113883.6.1 |
2‑L |
73578-7
|
Anionenlücke 4P ven.
|
2.16.840.1.113883.6.1 |
2‑L |
59828-4
|
Bilirubin ven.
|
2.16.840.1.113883.6.1 |
2‑L |
41652-9
|
Glucose ven.
|
2.16.840.1.113883.6.1 |
2‑L |
41654-5
|
Hct ven.
|
2.16.840.1.113883.6.1 |
1‑S |
02090
|
Hb-Derivate venös
|
1.2.40.0.34.5.11 |
2‑L |
30350-3
|
Hämoglobin ven.
|
2.16.840.1.113883.6.1 |
2‑L |
19227-8
|
Deoxy.Hämoglob. ven.
|
2.16.840.1.113883.6.1 |
2‑L |
2032-1
|
CO-Hämoglobin ven.
|
2.16.840.1.113883.6.1 |
2‑L |
2617-9
|
Methämoglobin ven.
|
2.16.840.1.113883.6.1 |
2‑L |
V00229
|
Sulfhämoglobin ven.
|
1.2.40.0.34.5.11 |
1‑S |
02100
|
Blutgasanalyse kapillär
|
1.2.40.0.34.5.11 |
2‑L |
24337-8
|
BGA Anf. Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
2745-8
|
pH Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
2020-6
|
pCO2 Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
2704-5
|
pO2 Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
19215-3
|
pO2-50 Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
50211-2
|
F-Shuntvolumen Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
2709-4
|
O2-Sättigung Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
1926-5
|
Base excess Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
19236-9
|
SBEC Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
1961-2
|
Bikarbonat Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
19239-3
|
Laktat Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
39792-7
|
Natrium Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
39790-1
|
Kalium Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
41644-6
|
Calcium ion. Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
51590-8
|
Chlorid Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
48421-2
|
CRP Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
V00453-3
|
Bilirubin Kap.
|
1.2.40.0.34.5.11 |
2‑L |
32016-8
|
Glucose Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
V00443-4
|
Kreatinin Kap.
|
1.2.40.0.34.5.11 |
2‑L |
42908-4
|
Hct Kap.
|
2.16.840.1.113883.6.1 |
1‑S |
02110
|
Hb-Derivate kapillär
|
1.2.40.0.34.5.11 |
2‑L |
30352-9
|
Hämoglobin Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
2715-1
|
Oxygen.Hämoglob. Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
19226-0
|
Deoxy.Hämoglobin Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
2031-3
|
CO-Hämoglobin Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
2616-1
|
Methämoglobin Kap.
|
2.16.840.1.113883.6.1 |
2‑L |
V00228
|
Sulfhämoglobin Kap.
|
1.2.40.0.34.5.11 |
1‑S |
02120
|
Hb-Derivate, gemischtvenös (Rechtsherzkatheter)
|
1.2.40.0.34.5.11 |
2‑L |
30351-1
|
Hämoglobin gev.
|
2.16.840.1.113883.6.1 |
2‑L |
34969-6
|
Oxygen.Hämoglob. Gev.
|
2.16.840.1.113883.6.1 |
2‑L |
19228-6
|
Deoxy.Hämoglobin gev.
|
2.16.840.1.113883.6.1 |
2‑L |
41648-7
|
CO-Hämoglobin gev.
|
2.16.840.1.113883.6.1 |
2‑L |
41607-3
|
Methämoglobin gev.
|
2.16.840.1.113883.6.1 |
2‑L |
V00227
|
Sulfhämoglobin gev.
|
1.2.40.0.34.5.11 |
2‑L |
19213-8
|
pH gemischt venös
|
2.16.840.1.113883.6.1 |
2‑L |
19212-0
|
pCO2 gemischt venös
|
2.16.840.1.113883.6.1 |
2‑L |
19211-2
|
pO2 gemischt venös
|
2.16.840.1.113883.6.1 |
2‑L |
19217-9
|
pO2-50 gemischt venös
|
2.16.840.1.113883.6.1 |
2‑L |
19224-5
|
O2-Sättigung gemischt venös
|
2.16.840.1.113883.6.1 |
2‑L |
19234-4
|
Base excess gemischt venös
|
2.16.840.1.113883.6.1 |
2‑L |
19229-4
|
Bikarbonat gemischt venös
|
2.16.840.1.113883.6.1 |
1‑S |
02130
|
BGA Sonstiges
|
1.2.40.0.34.5.11 |
2‑L |
8310-5
|
Körpertemperatur
|
2.16.840.1.113883.6.1 |
2‑L |
19993-5
|
Beatmungswert (FIO2)
|
2.16.840.1.113883.6.1 |
2‑L |
20124-4
|
Ventilationsmodus
|
2.16.840.1.113883.6.1 |
2‑L |
3151-8
|
O2-Zufuhr
|
2.16.840.1.113883.6.1 |
2‑L |
V00276
|
Kommentar BGA
|
1.2.40.0.34.5.11 |
2‑L |
11558-4
|
pH Blut
|
2.16.840.1.113883.6.1 |
2‑L |
45847-1
|
Sauerstofftherapie
|
2.16.840.1.113883.6.1 |
2‑L |
49701-6
|
pH temperaturkorrigiert /B
|
2.16.840.1.113883.6.1 |
2‑L |
2947-0
|
Natrium/B
|
2.16.840.1.113883.6.1 |
2‑L |
6298-4
|
Kalium/B
|
2.16.840.1.113883.6.1 |
2‑L |
1994-3
|
Calcium ionisiert/B
|
2.16.840.1.113883.6.1 |
2‑L |
38483-4
|
Kreatinin /B
|
2.16.840.1.113883.6.1 |
2‑L |
19991-9
|
AaDO2
|
2.16.840.1.113883.6.1 |
2‑L |
11559-2
|
Oxyhämoglobin /B
|
2.16.840.1.113883.6.1 |
2‑L |
20564-1
|
O2-Sättigung gem. /B
|
2.16.840.1.113883.6.1 |
2‑L |
2713-6
|
O2-Sättigung ber. /B
|
2.16.840.1.113883.6.1 |
2‑L |
4536-9
|
Deoxyhämoglobin /B
|
2.16.840.1.113883.6.1 |
2‑L |
55782-7
|
Hämoglobin /B
|
2.16.840.1.113883.6.1 |
2‑L |
11557-6
|
pCO2 /B
|
2.16.840.1.113883.6.1 |
2‑L |
11556-8
|
pO2 /B
|
2.16.840.1.113883.6.1 |
2‑L |
34705-4
|
pCO2 tem.-korr. /B
|
2.16.840.1.113883.6.1 |
2‑L |
19254-2
|
pO2 temp.-korr. /B
|
2.16.840.1.113883.6.1 |
2‑L |
11555-0
|
Base excess /B
|
2.16.840.1.113883.6.1 |
2‑L |
41276-7
|
Anionenlücke /B
|
2.16.840.1.113883.6.1 |
2‑L |
1959-6
|
Bikarbonat /B
|
2.16.840.1.113883.6.1 |
0‑S |
300
|
Hämatologie
|
1.2.40.0.34.5.11 |
1‑S |
03010
|
Blutbild
|
1.2.40.0.34.5.11 |
2‑L |
57021-8
|
Blutbild
|
2.16.840.1.113883.6.1 |
2‑L |
V00197
|
Blutbild 37 Grad
|
1.2.40.0.34.5.11 |
2‑L |
57782-5
|
Blutbild+Man. Diff.
|
2.16.840.1.113883.6.1 |
2‑L |
55429-5
|
kleines Blutbild
|
2.16.840.1.113883.6.1 |
2‑L |
50262-5
|
Retikulozyten
|
2.16.840.1.113883.6.1 |
2‑L |
26464-8
|
Leukozyten
|
2.16.840.1.113883.6.1 |
2‑L |
26515-7
|
Thrombozyten
|
2.16.840.1.113883.6.1 |
2‑L |
778-1
|
Thrombozyten abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
26453-1
|
Erythrozyten
|
2.16.840.1.113883.6.1 |
2‑L |
718-7
|
Hämoglobin
|
2.16.840.1.113883.6.1 |
2‑L |
20570-8
|
Hämatokrit
|
2.16.840.1.113883.6.1 |
2‑L |
30428-7
|
MCV
|
2.16.840.1.113883.6.1 |
2‑L |
28539-5
|
MCH
|
2.16.840.1.113883.6.1 |
2‑L |
28540-3
|
MCHC
|
2.16.840.1.113883.6.1 |
2‑L |
30385-9
|
RDW-CV
|
2.16.840.1.113883.6.1 |
2‑L |
30384-2
|
RDW-SD
|
2.16.840.1.113883.6.1 |
2‑L |
14196-0
|
Retikulozyten abs.
|
2.16.840.1.113883.6.1 |
2‑L |
4679-7
|
Retikulozyten rel.
|
2.16.840.1.113883.6.1 |
2‑L |
40665-2
|
Retikulozyt. abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
31112-6
|
Retikulozyt. rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
32349-3
|
Mittelfraktion (Mono, Eo, Baso) abs.
|
2.16.840.1.113883.6.1 |
2‑L |
32350-1
|
Mittelfraktion (Mono, Eo, Baso) rel.
|
2.16.840.1.113883.6.1 |
2‑L |
32154-7
|
Baso+Eo+Mono abs.
|
2.16.840.1.113883.6.1 |
2‑L |
32155-4
|
Baso+Eo+Mono rel.
|
2.16.840.1.113883.6.1 |
2‑L |
26499-4
|
Neutroph. Gran. abs.
|
2.16.840.1.113883.6.1 |
2‑L |
53115-2
|
Unreife neutrophile Granulozyten abs.
|
2.16.840.1.113883.6.1 |
2‑L |
26474-7
|
Lymphozyten abs.
|
2.16.840.1.113883.6.1 |
2‑L |
33830-1
|
Lymphoblasten abs.
|
2.16.840.1.113883.6.1 |
2‑L |
34926-6
|
Promonozyten abs.
|
2.16.840.1.113883.6.1 |
2‑L |
26484-6
|
Monozyten abs.
|
2.16.840.1.113883.6.1 |
2‑L |
26449-9
|
Eosinophile Gr. abs.
|
2.16.840.1.113883.6.1 |
2‑L |
26444-0
|
Basophile Gr.abs.
|
2.16.840.1.113883.6.1 |
2‑L |
51584-1
|
Gran., unreife abs.
|
2.16.840.1.113883.6.1 |
2‑L |
17789-9
|
LUC abs.
|
2.16.840.1.113883.6.1 |
2‑L |
26511-6
|
Neutroph. Gran. rel.
|
2.16.840.1.113883.6.1 |
2‑L |
26478-8
|
Lymphozyten rel.
|
2.16.840.1.113883.6.1 |
2‑L |
33831-9
|
Lymphoblasten rel.
|
2.16.840.1.113883.6.1 |
2‑L |
26485-3
|
Monozyten rel.
|
2.16.840.1.113883.6.1 |
2‑L |
26450-7
|
Eosinophile Gr. rel.
|
2.16.840.1.113883.6.1 |
2‑L |
30180-4
|
Basophile Gr.rel.
|
2.16.840.1.113883.6.1 |
2‑L |
38518-7
|
Gran., unreife rel.
|
2.16.840.1.113883.6.1 |
2‑L |
17788-1
|
LUC rel.
|
2.16.840.1.113883.6.1 |
2‑L |
51588-2
|
Granulozyten abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
753-4
|
Neutroph.Gr.abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
768-2
|
Segmentkern. abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
763-3
|
Stabkernige abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
739-3
|
Metamyeloz. abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
748-4
|
Myelozyten abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
781-5
|
Promyelozyt. abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
708-8
|
Blasten abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
732-8
|
Lymphozyten abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
V00043
|
Akt.Lymphoz.abs.mi.
|
1.2.40.0.34.5.11 |
2‑L |
734-4
|
Atyp.Lymphoz.abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
24105-9
|
Atypische Lymphozyten neoplastisch abs. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
34993-6
|
Kernschatten abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
35082-7
|
LGL abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
24103-4
|
Plasmazellen abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
33834-3
|
Plasm.Lymphoz.ab.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
6863-5
|
Prolymphozyt.abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
24107-5
|
Haarzellen abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
33856-6
|
Sezary-Zel. abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
13599-6
|
Promonozyten rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
743-5
|
Monozyten abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
712-0
|
Eosinoph.Gr.abs. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
705-4
|
Basophile Gr.abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51585-8
|
Sonstige Zel.abs.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
769-0
|
Segmentkern. rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
764-1
|
Stabkernige rel. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
28541-1
|
Metamyeloz. rel. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
749-2
|
Myelozyten rel. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
783-1
|
Promyelozyt. rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
709-6
|
Blasten rel. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
737-7
|
Lymphozyten rel. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
V00042
|
Akt.Lymphoz.rel.mi.
|
1.2.40.0.34.5.11 |
2‑L |
735-1
|
Atyp.Lymphoz.rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
24104-2
|
Atypische Lymphozyten neoplastisch rel. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
733-6
|
Atyp.Lymphoz.ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
34992-8
|
Kernschatten rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
7798-2
|
Kernschatten ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
11275-5
|
LGL rel. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
13047-6
|
Plasmazellen rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
40743-7
|
Plasmazellen ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
33835-0
|
Plasm.Lymphoz.rl.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
6746-2
|
Prolymphozyt.rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
24106-7
|
Haarzellen rel. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
33857-4
|
Sezary-Zel. rel. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
744-3
|
Monozyten rel. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
714-6
|
Eosinoph.Gr.rel. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
707-0
|
Basophile Gr.rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51586-6
|
Sonstige Zel.rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51644-3
|
Megakar.kerne ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
5908-9
|
Riesenthromb. ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
7796-6
|
Thromboz.aggr.ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51640-1
|
Thro.anisozyt.ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
738-5
|
Makrozyten ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51645-0
|
Mikromegakary.ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
765-8
|
Hypersegment. ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
803-7
|
Toxische Gran.ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
10378-8
|
Polychromasie ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
779-9
|
Poikilozytose ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
741-9
|
Mikrozyten ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
10376-2
|
Megalozyten ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
802-9
|
Kugelzellen ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
728-6
|
Hypochromasie ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
7793-3
|
Howell-Jolly. ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51630-2
|
Fragmentozyt.rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
800-3
|
Fragmentozyt. ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51638-5
|
Ery.aggregate ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
11274-8
|
Elliptozyten ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
7790-9
|
Echinozyten ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51589-0
|
Dyserythrop. ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
10377-0
|
Bleistiftzel. ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
703-9
|
Basoph.Tüpfelung mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51583-3
|
Anulozyten ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
702-1
|
Anisozytose ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51582-5
|
Anisochromas.ql.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
51639-3
|
Akanthozyten rel.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
7789-1
|
Akanthozyten ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
7791-7
|
Tränenzellen ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
10381-2
|
Target-Zellen mi.
|
2.16.840.1.113883.6.1 |
2‑L |
7797-4
|
Geldrollenb. ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
10380-4
|
Stomatozyten ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
801-1
|
Sichelzellen ql. mi.
|
2.16.840.1.113883.6.1 |
2‑L |
30392-5
|
Normoblast.(NRBC)ab.
|
2.16.840.1.113883.6.1 |
2‑L |
771-6
|
Normoblasten (NRBC) abs.
|
2.16.840.1.113883.6.1 |
2‑L |
19048-8
|
Normoblast.(NRBC)Rt.
|
2.16.840.1.113883.6.1 |
2‑L |
772-4
|
Normobl.(NRBC)ab.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
18309-5
|
Normobl.(NRBC)Rt.mi.
|
2.16.840.1.113883.6.1 |
2‑L |
5909-7
|
Blutausstr. Interpr.
|
2.16.840.1.113883.6.1 |
2‑L |
42810-2
|
Retikulozyten Hb
|
2.16.840.1.113883.6.1 |
2‑L |
31111-8
|
RPI
|
2.16.840.1.113883.6.1 |
2‑L |
51636-9
|
IRF(Ret.,unreif)abs.
|
2.16.840.1.113883.6.1 |
2‑L |
33516-6
|
IRF(Ret.,unreif)rel.
|
2.16.840.1.113883.6.1 |
2‑L |
51634-4
|
Reti,mittelreif abs.
|
2.16.840.1.113883.6.1 |
2‑L |
34420-0
|
Reti,mittelreif rel.
|
2.16.840.1.113883.6.1 |
2‑L |
51635-1
|
Reti., reif abs.
|
2.16.840.1.113883.6.1 |
2‑L |
34419-2
|
Reti., reife rel.
|
2.16.840.1.113883.6.1 |
2‑L |
51643-5
|
HLSc-Reti. abs.
|
2.16.840.1.113883.6.1 |
2‑L |
51642-7
|
HLSc-Reti. rel.
|
2.16.840.1.113883.6.1 |
2‑L |
51637-7
|
Thrombokrit
|
2.16.840.1.113883.6.1 |
2‑L |
28542-9
|
MPV
|
2.16.840.1.113883.6.1 |
2‑L |
32623-1
|
MPV (Mittleres Thrombozytenvolumen)
|
2.16.840.1.113883.6.1 |
2‑L |
48386-7
|
Riesenthrombozyten Ratio
|
2.16.840.1.113883.6.1 |
2‑L |
32207-3
|
PDW-SD
|
2.16.840.1.113883.6.1 |
2‑L |
51631-0
|
PDW-CV
|
2.16.840.1.113883.6.1 |
2‑L |
51632-8
|
Retik.Thromboz.abs.
|
2.16.840.1.113883.6.1 |
2‑L |
51633-6
|
Retik.Thromboz.rel.
|
2.16.840.1.113883.6.1 |
2‑L |
40741-1
|
PLTCLU
|
2.16.840.1.113883.6.1 |
2‑L |
50794-7
|
Osm.E.R.Hämol.beginn
|
2.16.840.1.113883.6.1 |
2‑L |
50795-4
|
Osm.E.R.Totalhämol.
|
2.16.840.1.113883.6.1 |
2‑L |
34964-7
|
Osmot.E.R. Interpr.
|
2.16.840.1.113883.6.1 |
2‑L |
12710-0
|
Hämoglobinopath. Scr
|
2.16.840.1.113883.6.1 |
2‑L |
4546-8
|
Hämoglobin A
|
2.16.840.1.113883.6.1 |
2‑L |
4547-6
|
Hämoglobin A1
|
2.16.840.1.113883.6.1 |
2‑L |
4551-8
|
Hämoglobin A2
|
2.16.840.1.113883.6.1 |
2‑L |
4621-9
|
Hämoglobin S
|
2.16.840.1.113883.6.1 |
2‑L |
4579-9
|
Hämoglobin F
|
2.16.840.1.113883.6.1 |
2‑L |
1783-0
|
Alk.Phosphataseindex
|
2.16.840.1.113883.6.1 |
2‑L |
33249-4
|
Hyperchromasie ql. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
774-0
|
Ovalozyten ql. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
7795-8
|
Pappenheimer-Körper ql. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
18312-9
|
Thrombozytensatellitose ql. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
33216-3
|
Ungranulierte Thrombozyten ql. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
50672-5
|
Toxische Vakuolisierung ql. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
18311-1
|
Pelger-Huet-Zellen ql. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
60526-1
|
Pseudo Pelger Huet-Zellen ql. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
71369-3
|
Dysplastische neutrophile Granulopoese ql. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
7792-5
|
Döhle-Körper ql. mikr.
|
2.16.840.1.113883.6.1 |
2‑L |
11281-3
|
Auerstäbchen ql. mikr.
|
2.16.840.1.113883.6.1 |
1‑S |
03020
|
Knochenmark Morphologie
|
1.2.40.0.34.5.11 |
2‑L |
74222-1
|
Material /KM
|
2.16.840.1.113883.6.1 |
2‑L |
66119-9
|
Biopsie /KM
|
2.16.840.1.113883.6.1 |
2‑L |
48807-2
|
Ausstriche /KM
|
2.16.840.1.113883.6.1 |
2‑L |
38519-5
|
KM Morphologie
|
2.16.840.1.113883.6.1 |
2‑L |
74232-0
|
Zellreichtum /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11128-6
|
Segm.Gran. rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
11103-9
|
Stabk.Gran. rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
11111-2
|
Metamyeloz.rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
11114-6
|
Myelozyten rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
11120-3
|
Promyeloz. rel. /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11113-8
|
Myeloblasten rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
11108-8
|
Lymphozyten rel. /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11118-7
|
Plasmaz. rel. /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11112-0
|
Monozyten rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
11106-2
|
Eos.Gran.rel. /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11105-4
|
Basoph.Gran.rel. /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11150-0
|
Blasten rel. /KM
|
2.16.840.1.113883.6.1 |
2‑L |
51579-1
|
Normoblast. rel. /KM
|
2.16.840.1.113883.6.1 |
2‑L |
51629-4
|
Makroblast. rel. /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11124-5
|
Proerythrobl.rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
11110-4
|
Megakaryozy.rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
51580-9
|
Makrophagen rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
51581-7
|
Sonst.Zellen rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
51268-1
|
CD23 Zellen rel./KM
|
2.16.840.1.113883.6.1 |
2‑L |
13513-7
|
Eisenfärbung /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11016-3
|
Esterase-Fbg (unsp.)
|
2.16.840.1.113883.6.1 |
2‑L |
9786-5
|
PAS-Färbung
|
2.16.840.1.113883.6.1 |
2‑L |
11018-9
|
POX(Peroxidase)-Fbg
|
2.16.840.1.113883.6.1 |
2‑L |
11020-5
|
Saure-Phosphat.-Fbg n. Tartrathemmung
|
2.16.840.1.113883.6.1 |
2‑L |
11019-7
|
Sudan-Schwarz-Fbg
|
2.16.840.1.113883.6.1 |
2‑L |
51628-6
|
KM-Befundinterpr.
|
2.16.840.1.113883.6.1 |
2‑L |
57764-3
|
KM mikr. Bef.-Intpr.
|
2.16.840.1.113883.6.1 |
2‑L |
40687-6
|
Myelopoetische Zellen /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11115-3
|
Neutrophile Granulozyten /KM
|
2.16.840.1.113883.6.1 |
2‑L |
40689-2
|
Erythropoetische Zellen /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11107-0
|
Atypische Lymphozyten /KM
|
2.16.840.1.113883.6.1 |
2‑L |
11138-5
|
Myelo-/Erythropoese /KM
|
2.16.840.1.113883.6.1 |
2‑L |
50726-9
|
Retikulumzellen /KM
|
2.16.840.1.113883.6.1 |
1‑S |
03030
|
Immunphänotypisierung
|
1.2.40.0.34.5.11 |
2‑L |
45270-6
|
Ak. Leukämiepanel FC
|
2.16.840.1.113883.6.1 |
2‑L |
45269-8
|
Chr.Leukämiepanel FC
|
2.16.840.1.113883.6.1 |
2‑L |
54225-8
|
Immunstatus
|
2.16.840.1.113883.6.1 |
2‑L |
49120-9
|
Immundefizienz Verl.
|
2.16.840.1.113883.6.1 |
2‑L |
54228-2
|
CLL Panel FC
|
2.16.840.1.113883.6.1 |
2‑L |
54229-0
|
T-Zell Panel FC
|
2.16.840.1.113883.6.1 |
2‑L |
54227-4
|
Ak. Lymphompanel FC
|
2.16.840.1.113883.6.1 |
2‑L |
54226-6
|
Lymphompanel FC
|
2.16.840.1.113883.6.1 |
2‑L |
V00116
|
Flowzytometrie Blut
|
1.2.40.0.34.5.11 |
2‑L |
V00117
|
Flowzytometrie BAL
|
1.2.40.0.34.5.11 |
2‑L |
V00118
|
Flowzytometrie /L
|
1.2.40.0.34.5.11 |
2‑L |
V00119
|
Flowzytometrie KM
|
1.2.40.0.34.5.11 |
2‑L |
V00120
|
Flowzytometrie SM
|
1.2.40.0.34.5.11 |
2‑L |
55164-8
|
PNH-Diagnostik
|
2.16.840.1.113883.6.1 |
2‑L |
V00211
|
Stammzell.(34+)[Leu]
|
1.2.40.0.34.5.11 |
2‑L |
14136-6
|
Stammzell.(34+) abs.
|
2.16.840.1.113883.6.1 |
2‑L |
V00065
|
CD64 AG-D.[Ne.Gran.]
|
1.2.40.0.34.5.11 |
2‑L |
V00057
|
CD64 AG-Zahl/Gran.
|
1.2.40.0.34.5.11 |
2‑L |
V00066
|
HLA-DR AG-D.[Monoz.]
|
1.2.40.0.34.5.11 |
2‑L |
30364-4
|
Lymphozyten abs. FC
|
2.16.840.1.113883.6.1 |
2‑L |
30365-1
|
Lymphozyten rel. FC
|
2.16.840.1.113883.6.1 |
2‑L |
V00237
|
Monozyten abs. FC
|
1.2.40.0.34.5.11 |
2‑L |
V00215
|
Monozyten rel. FC
|
1.2.40.0.34.5.11 |
2‑L |
30394-1
|
Granulozyten abs.
|
2.16.840.1.113883.6.1 |
2‑L |
30395-8
|
Granulozyten rel.
|
2.16.840.1.113883.6.1 |
2‑L |
8116-6
|
B-Zellen (19+) abs.
|
2.16.840.1.113883.6.1 |
2‑L |
8122-4
|
T-Zellen (3+) abs.
|
2.16.840.1.113883.6.1 |
2‑L |
24467-3
|
Helfer-T-Z.(4+) abs.
|
2.16.840.1.113883.6.1 |
2‑L |
14135-8
|
Zytotox.T-Z.(8+)abs.
|
2.16.840.1.113883.6.1 |
2‑L |
54218-3
|
CD4/CD8-Ratio
|
2.16.840.1.113883.6.1 |
2‑L |
26568-6
|
aktiv.T-Z.(DR+)abs.
|
2.16.840.1.113883.6.1 |
2‑L |
9728-7
|
NK-Zellen abs.
|
2.16.840.1.113883.6.1 |
2‑L |
42188-3
|
NK-like T-Zell. abs.
|
2.16.840.1.113883.6.1 |
2‑L |
V00212
|
B-Zellen (19+) [Leu]
|
1.2.40.0.34.5.11 |
2‑L |
V00201
|
B-Zellen (19+) [Ly]
|
1.2.40.0.34.5.11 |
2‑L |
V00202
|
T-Zellen (3+) [Ly]
|
1.2.40.0.34.5.11 |
2‑L |
V00203
|
Helfer-T-Z.(4+) [Ly]
|
1.2.40.0.34.5.11 |
2‑L |
V00204
|
Zytotox.T-Z.(8+)[Ly]
|
1.2.40.0.34.5.11 |
2‑L |
V00205
|
aktiv.T-Z.(DR+)[Ly]
|
1.2.40.0.34.5.11 |
2‑L |
V00206
|
NK-Zellen [Ly]
|
1.2.40.0.34.5.11 |
2‑L |
V00207
|
NK-like T-Zellen[Ly]
|
1.2.40.0.34.5.11 |
2‑L |
V00213
|
CD20+ Zellen [Leu]
|
1.2.40.0.34.5.11 |
2‑L |
9558-8
|
CD20+ Zellen abs.
|
2.16.840.1.113883.6.1 |
2‑L |
V00238
|
CD19+5+ [BZ]
|
1.2.40.0.34.5.11 |
2‑L |
9561-2
|
CD19+5+ abs.
|
2.16.840.1.113883.6.1 |
2‑L |
V00239
|
CD19+23+ [BZ]
|
1.2.40.0.34.5.11 |
2‑L |
V00071
|
CD19+23+ abs.
|
1.2.40.0.34.5.11 |
2‑L |
60436-3
|
CD19+25+ [BZ] abs.
|
2.16.840.1.113883.6.1 |
2‑L |
V00240
|
CD19+kappa+ [BZ]
|
1.2.40.0.34.5.11 |
2‑L |
50664-2
|
CD19+kappa+ abs.
|
2.16.840.1.113883.6.1 |
2‑L |
V00241
|
CD19+lambda+ [BZ]
|
1.2.40.0.34.5.11 |
2‑L |
50665-9
|
CD19+lambda+ abs.
|
2.16.840.1.113883.6.1 |
2‑L |
V00242
|
K/L-Ratio [B-Zellen]
|
1.2.40.0.34.5.11 |
2‑L |
V00072
|
Klonale Popul. [Leu]
|
1.2.40.0.34.5.11 |
2‑L |
V00073
|
Klonale Popul. abs.
|
1.2.40.0.34.5.11 |
2‑L |
V00074
|
Klonale Pop.[Leu]/KM
|
1.2.40.0.34.5.11 |
2‑L |
26997-7
|
CD3+25+ [Ly] abs.
|
2.16.840.1.113883.6.1 |
2‑L |
V00214
|
CD52+ Zellen [Leu]
|
1.2.40.0.34.5.11 |
2‑L |
V00067
|
CD52+ Zellen abs.
|
1.2.40.0.34.5.11 |
2‑L |
V00068
|
CD52 AG-Ex.[path.P.]
|
1.2.40.0.34.5.11 |
2‑L |
V00069
|
CD41 AG-Expr.[Thro.]
|
1.2.40.0.34.5.11 |
2‑L |
V00070
|
PAC-1+[Thrombozyten]
|
1.2.40.0.34.5.11 |
2‑L |
V00208
|
B-Zellen(19+)[Ly]/SM
|
1.2.40.0.34.5.11 |
2‑L |
V00209
|
T-Zellen(3+)[Ly]/SM
|
1.2.40.0.34.5.11 |
2‑L |
V00075
|
Helf-T-Z.(4+)[Ly]/SM
|
1.2.40.0.34.5.11 |
2‑L |
V00076
|
Zytot.T-Z(8+)[Ly]/SM
|
1.2.40.0.34.5.11 |
2‑L |
18266-7
|
CD4/CD8-Ratio /SM
|
2.16.840.1.113883.6.1 |
2‑L |
57740-3
|
HLA-DR rel. /SM
|
2.16.840.1.113883.6.1 |
2‑L |
V00210
|
akt.T-Z.(DR+)[Ly]/SM
|
1.2.40.0.34.5.11 |
2‑L |
V00077
|
NK-Zellen [Ly]/SM
|
1.2.40.0.34.5.11 |
2‑L |
V00078
|
NK-like T-Z. [Ly]/SM
|
1.2.40.0.34.5.11 |
2‑L |
V00087
|
B-Zellen(19+)abs./BL
|
1.2.40.0.34.5.11 |
2‑L |
V00088
|
T-Zellen(3+)abs./BL
|
1.2.40.0.34.5.11 |
2‑L |
V00089
|
Helf-T-Z.(4+)abs./BL
|
1.2.40.0.34.5.11 |
2‑L |
V00090
|
Zytot.T-Z(8+)abs./BL
|
1.2.40.0.34.5.11 |
2‑L |
V00083
|
CD4/CD8-Ratio /BL
|
1.2.40.0.34.5.11 |
2‑L |
V00091
|
akt.T-Z.(DR+)abs./BL
|
1.2.40.0.34.5.11 |
2‑L |
V00092
|
NK-Zellen abs./BL
|
1.2.40.0.34.5.11 |
2‑L |
V00093
|
NK-like T-Z. abs./BL
|
1.2.40.0.34.5.11 |
2‑L |
V00079
|
B-Zellen(19+)[Ly]/BL
|
1.2.40.0.34.5.11 |
2‑L |
V00080
|
T-Zellen(3+)[Ly]/BL
|
1.2.40.0.34.5.11 |
2‑L |
V00081
|
Helf-T-Z.(4+)[Ly]/BL
|
1.2.40.0.34.5.11 |
2‑L |
V00082
|
Zytot.T-Z(8+)[Ly]/BL
|
1.2.40.0.34.5.11 |
2‑L |
V00084
|
akt.T-Z.(DR+)[Ly]/BL
|
1.2.40.0.34.5.11 |
2‑L |
V00085
|
NK-Zellen [Ly]/BL
|
1.2.40.0.34.5.11 |
2‑L |
V00086
|
NK-like T-Z. [Ly]/BL
|
1.2.40.0.34.5.11 |
2‑L |
V00445-9
|
B-Zellen(19+)[Ly] /L
|
1.2.40.0.34.5.11 |
2‑L |
V00444-2
|
T-Zellen(3+)[Ly] /L
|
1.2.40.0.34.5.11 |
2‑L |
V00447-5
|
Helf-T-Z.(4+)[Ly] /L
|
1.2.40.0.34.5.11 |
2‑L |
V00448-3
|
Zytot.T-Z(8+)[Ly] /L
|
1.2.40.0.34.5.11 |
2‑L |
V00449-1
|
CD4/CD8-Ratio /L
|
1.2.40.0.34.5.11 |
2‑L |
V00446-7
|
NK-Zellen [Ly] /L
|
1.2.40.0.34.5.11 |
2‑L |
69052-9
|
Befundint.Immunphän.
|
2.16.840.1.113883.6.1 |
2‑L |
8124-0
|
T-Lymphozyten [Lympho]
|
2.16.840.1.113883.6.1 |
2‑L |
8117-4
|
B-Lymphozyten [Lympho]
|
2.16.840.1.113883.6.1 |
2‑L |
8123-2
|
Helferzellen [Lympho]
|
2.16.840.1.113883.6.1 |
2‑L |
8101-8
|
Suppressorzellen [Lympho]
|
2.16.840.1.113883.6.1 |
2‑L |
18408-5
|
aktivierte T-Zellen [Lympho]
|
2.16.840.1.113883.6.1 |
2‑L |
8112-5
|
NK-Zellen [Lympho]
|
2.16.840.1.113883.6.1 |
2‑L |
17135-5
|
zytotox T-Zellen [Lympho]
|
2.16.840.1.113883.6.1 |
2‑L |
26858-1
|
zytotox T-Zellen abs.
|
2.16.840.1.113883.6.1 |
2‑L |
32760-1
|
Beschriebene Population /Sondermaterial
|
2.16.840.1.113883.6.1 |
2‑L |
20592-2
|
CD19 /Sondermaterial
|
2.16.840.1.113883.6.1 |
2‑L |
9559-6
|
CD5
|
2.16.840.1.113883.6.1 |
2‑L |
8132-3
|
CD5
|
2.16.840.1.113883.6.1 |
2‑L |
27071-0
|
CD45
|
2.16.840.1.113883.6.1 |
2‑L |
25165-2
|
CD23
|
2.16.840.1.113883.6.1 |
2‑L |
9554-7
|
CD10
|
2.16.840.1.113883.6.1 |
2‑L |
21013-8
|
CD22
|
2.16.840.1.113883.6.1 |
2‑L |
26728-6
|
CD38
|
2.16.840.1.113883.6.1 |
2‑L |
8126-5
|
CD38
|
2.16.840.1.113883.6.1 |
2‑L |
9555-4
|
CD11c
|
2.16.840.1.113883.6.1 |
2‑L |
31123-3
|
CD25
|
2.16.840.1.113883.6.1 |
2‑L |
14113-5
|
CD56
|
2.16.840.1.113883.6.1 |
2‑L |
9563-8
|
CD7
|
2.16.840.1.113883.6.1 |
2‑L |
50972-9
|
CD138
|
2.16.840.1.113883.6.1 |
2‑L |
27011-6
|
CD14
|
2.16.840.1.113883.6.1 |
Dieses Value Set beinhaltet 4730 Codes. Um die Publikationsgröße überschaubar zu halten,
wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt.
|
|
0‑L |
OTH
|
anders
|
2.16.840.1.113883.5.1008 |